This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Monday, May 19, 2014
Action Plan for the Prevention Care Treatment of Viral Hepatitis (2014-2016)
Observing National Hepatitis Testing Day
A statement by Assistant Secretary for Health Howard Koh, MD, MPH
May 19 is the third national Hepatitis Testing Day. The observance was established in the Action Plan for the Prevention Care Treatment of Viral Hepatitis to raise greater awareness of an often silent epidemic. Chronic viral hepatitis affects as many as 5.3 million Americans. Most do not know that they are infected, and are at risk for severe, even fatal, complications from the disease, and can spread the virus to others.
Through this observance, we hope to increase the number of people who know their hepatitis B and hepatitis C status. We encourage people to take a brief online Hepatitis Risk Assessment available from the Centers for Disease Control and Prevention. The assessment lets people determine their risk by answering several brief questions anonymously. They can then print tailored recommendations based on CDC’s testing and vaccination guidelines to discuss with their health care provider.
We applaud the many health departments, community-based organizations and others that are offering free hepatitis screenings on Hepatitis Testing Day. Please join us in this observance by learning more about viral hepatitis, getting tested if appropriate for you, and sharing what you know with others.
For more information on Hepatitis Testing Day, visit http://aids.gov/news-and-events/awareness-days/hepatitis/.
###
Note: All HHS press releases, fact sheets and other news materials are available at http://www.hhs.gov/news.
Read the Action Plan for the Prevention, Care, & Treatment of Viral Hepatitis (2014-2016)
(PDF 2MB).
Download a factsheet (PDF 714KB) about the updated Viral Hepatitis Action Plan.
Read the press statement about the updated plan.
Read the Latest Blog Posts About the Action Plan
Blog posts about the Action Plan are shared via the AIDS.gov blog.
Read the latest posts:
What Every Women Needs to Know about Hepatitis B and C
May 15, 2014
Raising Awareness about Viral Hepatitis in the Hispanic Community
May 14, 2014
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment